6838.TWO
Price:
$28
Market Cap:
$4.23B
Formosa Pharmaceuticals, Inc., a late-preclinical and early clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing APP13007, an aqueous-based ophthalmic nanosuspension that is in Phase III clinical trial for the treatment of post-operative pain and inflammatory eye conditions; TSY-0110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002, a topical antibiotic for infectious eye diseases, such as blepharitis; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorec...[Read more]
Industry
Biotechnology
IPO Date
2021-10-07
Stock Exchange
TWO
Ticker
6838.TWO
According to Formosa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -14.00. This represents a change of -32.77% compared to the average of -20.82 of the last 4 quarters.
The mean historical PE Ratio of Formosa Pharmaceuticals, Inc. over the last ten years is -15.11. The current -14.00 PE Ratio has changed 9.16% with respect to the historical average. Over the past ten years (40 quarters), 6838.TWO's PE Ratio was at its highest in in the June 2025 quarter at 18.69. The PE Ratio was at its lowest in in the March 2024 quarter at -95.07.
Average
-15.11
Median
-15.80
Minimum
-31.82
Maximum
0
Discovering the peaks and valleys of Formosa Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.36%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -31.82
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -31.82 | 64.78% |
| 2023 | -19.31 | 42.37% |
| 2022 | -13.56 | 70.36% |
| 2021 | -7.96 | -55.86% |
| 2020 | -18.04 | -Infinity% |
The current PE Ratio of Formosa Pharmaceuticals, Inc. (6838.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-21.56
5-year avg
-18.14
10-year avg
-15.11
Formosa Pharmaceuticals, Inc.’s PE Ratio is less than AnnJi (-13.54), less than Senhwa Biosciences, Inc. (-12.93), less than Energenesis Biomedical CO.,LTD. (-13.73), greater than BRIM Biotechnology, Inc. (-16.03), greater than UnicoCell Biomed Co., Ltd. (-53.80), less than TWi Biotechnology, Inc. (-10.92), greater than Medigen Biotechnology Corp. (-69.45), less than Orient EuroPharma Co., Ltd. (-11.98), less than Synbio Tech Inc. (16.92), greater than Shine-On BioMedical Co.,Ltd. (-29.87),
| Company | PE Ratio | Market cap |
|---|---|---|
| -13.54 | $4.31B | |
| -12.93 | $3.61B | |
| -13.73 | $3.92B | |
| -16.03 | $3.72B | |
| -53.80 | $4.79B | |
| -10.92 | $2.08B | |
| -69.45 | $4.33B | |
| -11.98 | $3.89B | |
| 16.92 | $3.23B | |
| -29.87 | $3.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Formosa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Formosa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Formosa Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Formosa Pharmaceuticals, Inc. (6838.TWO)?
What is the highest PE Ratio for Formosa Pharmaceuticals, Inc. (6838.TWO)?
What is the 3-year average PE Ratio for Formosa Pharmaceuticals, Inc. (6838.TWO)?
What is the 5-year average PE Ratio for Formosa Pharmaceuticals, Inc. (6838.TWO)?
How does the current PE Ratio for Formosa Pharmaceuticals, Inc. (6838.TWO) compare to its historical average?